Nā ʻano hana
Ka palena ʻike: 100pg/mL;
Laina Linear: 100~35000pg/mL ;
Koefficient huikau laina R ≥ 0.990;
Ka pololei: i loko o ka puʻupuʻu CV ʻo ≤ 15%;ma waena o nā pūʻulu CV he ≤ 20%;
Pono: ʻaʻole ʻoi aku ka ʻae ʻana o nā hopena ana ma mua o ± 15% ke hoʻāʻo ʻia ka calibrator pololei i hoʻomākaukau ʻia e NT-proBNP national standard a i ʻole standardized accuracy calibrator.
1. E mālama i ka mea ʻike maka ma 2~30 ℃.Kūpaʻa ka buffer a hiki i 18 mahina.
2. E kūʻai i ka cassette hōʻike Aehealth Ferritin Rapid Quantitative ma 2~30 ℃, a hiki i ka 18 mahina.
3. Pono e hoʻohana i ka pahu hoʻāʻo i loko o 1 hola ma hope o ka wehe ʻana i ka ʻeke.
ʻO ka N-terminal prohormone o ka lolo natriuretic peptide (NT-proBNP) nona ka 76 amino acids, ʻo ia ka ʻāpana N-terminal o ka prohormone o ka lolo natriuretic peptide.Hoʻohana ʻia ka pae NT-proBNP i loko o ke koko no ka nānā ʻana, ka ʻike ʻana i ka hōʻeha ʻole o ka naʻau congestive (CHF) a pono paha e hoʻokumu i ka prognosis i ka hāʻule ʻana o ka naʻau, ʻoiai ʻoi aku ka kiʻekiʻe o nā maʻi me ka hopena ʻino.He mea pono paha ka NT-proBNP no ka haʻalele ʻana i ka ventricular dysfunction i nā poʻe maʻi me ka mōʻaukala manaʻo o ka maʻi puʻuwai a hoʻohana ʻia e kōkua i ka hoʻokumu ʻana i kahi probability pretest, ʻo ia hoʻi e hiki ke kōkua nui i ke kūpono o ka hāʻawi ʻana i ka mea maʻi a me ka optimization o ka lāʻau lapaʻau.